Tetrahydrocannabinol News and Research

RSS

Researchers use video conferencing app to study memory effects of high-potency cannabis

Even before the pandemic made Zoom ubiquitous, Washington State University researchers were using the video conferencing app to research a type of cannabis that is understudied: the kind people actually use.

8 Jul 2021

Many people with fibromyalgia substitute CBD for opioids and pain medications, finds study

Fibromyalgia is one of many chronic pain conditions that remains stubbornly difficult to treat.

24 Jun 2021

Immune system dysfunction can alter the link between cannabis use and psychosis

The presence of pro-inflammatory cytokines in the blood can boost the effects of daily cannabis use and heighten the risk of developing psychosis in adulthood.

16 Jun 2021

Streamline Cannabinoid Analyses with Restek’s New Neutrals Mix

Restek’s new cannabinoid 9-component mix streamlines cannabinoid analyses.

From Restek Corporation 3 Jun 2021

Zebrafish study shows how early exposure to cannabinoids reduces later neural activity

Zebrafish exposed to the leading cannabinoids found in cannabis in the earliest stages of development suffer a significant drop in neural activity later in life, according to a University of Alberta study that has implications for prenatal development in humans.

2 Jun 2021

New peptides allow cannabis-derived drugs to fight pain in mice without side effects

An international team, led by researchers from Pompeu Fabra University (UPF) in Barcelona, Spain, David Andreu and Rafael Maldonado, has developed a peptides family that allows delta-9-tetrahydrocannabinol (THC), the main component of Cannabis sativa, to fight pain in mice without side effects.

20 May 2021

New peptide could allow cannabis to fight pain without side effects

Many people live with chronic pain, and in some cases, cannabis can provide relief. But the drug also can significantly impact memory and other cognitive functions.

12 May 2021

Babies born to mothers with cannabis use disorder more likely to experience negative health outcomes

A study of almost 5 million live births in California by researchers at the Herbert Wertheim School of Public Health and Human Longevity Science at University of California San Diego reports that babies born to mothers diagnosed with cannabis use disorder were more likely to experience negative health outcomes, such as preterm birth and low birth weight, than babies born to mothers without a cannabis use disorder diagnosis.

22 Apr 2021

Study identifies a 'window of impairment' caused by cannabis intoxication

A comprehensive analysis of 80 scientific studies has identified a 'window of impairment' of between three and 10 hours caused by moderate to high doses of the intoxicating component of cannabis, tetrahydrocannabinol (THC).

12 Apr 2021

Study shows persistence of marijuana THC in breast milk for six weeks

In a new study published in JAMA Pediatrics, researchers at Children's Hospital Colorado have found that tetrahydrocannabinol (THC), the psychoactive component of marijuana, stays in breast milk for up to six weeks.

8 Mar 2021

Cannabinoid receptor agonist shows potential protective effect on SARS-CoV-2-infected human heart cells

As scientists continue to search for effective antidotes to direct and indirect damage caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a new preprint research paper posted to the bioRxiv* server demonstrates the potential of cannabinoid receptor agonists to alleviate myocardial damage in this condition even in the absence of any inhibitory effect on viral infection as such.

23 Feb 2021

Medicinal cannabis improves outcomes in Parkinson's patients

With medicinal cannabis now legalized in many parts of the world, there is growing interest in its use to alleviate symptoms of many illnesses including Parkinson's disease (PD).

27 Jan 2021

Texas Biomed to investigate the effects of cannabinoids on HIV-associated neurocognitive disorder

The National Institutes of Health (NIH) awarded Professor Mahesh Mohan, D.V.M., Ph.D., and collaborators more than $3.5 million over five years to investigate the effects of cannabinoids on Human Immunodeficiency Virus (HIV) associated neurocognitive disorder (HAND).

11 Dec 2020

Medically active component of cannabis does not impact driving ability, study shows

A landmark study on how cannabis affects driving ability has shown that cannabidiol (CBD), a cannabis component now widely used for medical purposes, does not impair driving, while moderate amounts of the main intoxicating component tetrahydrocannabinol (THC) produce mild driving impairment lasting up to four hours.

1 Dec 2020

Tetrahydrocannabinol News and Research

Researchers use video conferencing app to study memory effects of high-potency cannabis

Many people with fibromyalgia substitute CBD for opioids and pain medications, finds study

Immune system dysfunction can alter the link between cannabis use and psychosis

Streamline Cannabinoid Analyses with Restek’s New Neutrals Mix

Zebrafish study shows how early exposure to cannabinoids reduces later neural activity

New peptides allow cannabis-derived drugs to fight pain in mice without side effects

New peptide could allow cannabis to fight pain without side effects

Babies born to mothers with cannabis use disorder more likely to experience negative health outcomes

Study identifies a 'window of impairment' caused by cannabis intoxication

Study shows persistence of marijuana THC in breast milk for six weeks

Cannabinoid receptor agonist shows potential protective effect on SARS-CoV-2-infected human heart cells

Medicinal cannabis improves outcomes in Parkinson's patients

Texas Biomed to investigate the effects of cannabinoids on HIV-associated neurocognitive disorder

Medically active component of cannabis does not impact driving ability, study shows

Cannabidiol oils are equally or less effective at inhibiting certain cancer cell lines

USask researchers to study how cannabis use during pregnancy affects fetus' brain development

Study examines the long-term health effects of vaping, e-cigarettes on children

Study pinpoints heating element in vaping devices as cause for lung injuries

Cannabinoids cause changes in the brain that leads to deficiencies in social interaction

Treatment with a cannabinoid prevented the development of colon cancers in mice

Pittcon Highlights: Cannabis & Psychedelic eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News